Antarelix

N/A

Report date: 2026/03/10 20:00:16
NME

Base Information

Drug NameAntarelix
Drug Alias Name替维瑞克Teverelix安雷利克斯teverelixumTZTX-001 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGonadotropin-releasing hormone antagonists
TargetsGonadotropin-releasing hormone
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryLithuania
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCOSCIENS Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesAntev LtdMedicus Pharma Ltd
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A